9th Annual Biomarkers Congress

Cell Biology: University of Texas, MD Anderson

Total Score People Score Events Score
113 92 57
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Drug Discovery in Industry, Academia, and Government: What Is the Track Record? Michael A. White
Clinical Trial Design in the Genomic Era Co-Chairpersons: Donald A. Berry, The University of Texas MD Anderson Cancer Center, Houston, TX, and George W. Sledge, Jr., Stanford University School of Medicine, Stanford, CA Donald Berry
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Gordon Mills
Bridging the Gap Between Clinical Research and Laboratory Investigation: Utilizing Presurgical Clinical Trials to Investigate Anti-CTLA-4 Immunotherapy Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX Padmanee Sharma
Whole Body Metabolism and Cancer Chairperson: Philipp E. Scherer, UT Southwestern Medical Center, Dallas, TX Philipp Scherer
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY George A. Calin
Identifying Novel Redox Signaling Pathways for Cancer Chemoprevention: From Fly to the Mouse Garth Powis, The University of Texas MD Anderson Cancer Center, Houston, TX Garth Powis
PAK Family of Kinases in Human Cancer: Past, Present, and Future Rakesh Kumar, George Washington University, Washington, DC Rakesh Kumar
March 3, 2013 Understanding Dendritic Cell Biology to Advance Disease Therapies (C2) Biochemical Characterization of Nucleic Acid Sensors in Dendritic Cells Yong-Jun Liu
March 21, 2012 The Houston Aortic Symposium What I Have Learned from Open Repair of TAAA Anthony L. Estrera
SESSION VI | DTAA Anthony L. Estrera
SESSION ix | ABSTRACTS Anthony L. Estrera
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Genomic alterations in gingivobuccal cancer: Results from whole-exome resequencing Sadhan Majumder
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation Raymond N DuBois
Plenary Session 5 | Cancer Prevention and Chemoprevention Raymond N DuBois
Day in Review Raymond N DuBois
Session 4 | Molecular Epidemiology of Cancer: Towards Personalized Risk Assessment, Prevention, and Therapy Xifeng Wu
November 18, 2011 16th Annual Perspectives In Thoracic Oncology New insights in the management of mesothelioma Anne Tsao
November 15, 2011 Cosa 38th Annual Scientific Meeting Management of Ta and T1 bladder cancer Michael Wallace
November 12, 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Cancer interception and reverse migration Scott M Lippman
Educational Session 1 | Treatment of Premalignant Conditions Scott M Lippman
Novel agents for epigenetic therapy Jean-Pierre Issa
Is there a role for metformin in cancer therapeutics? Ana Gonzalez-Angulo
July 10, 2011 Nutritional Immunology: Role in Health and Disease Omega-3 fatty acid regulation of T-lymphocytes Christopher Jolly
Lipid rafts and immune function Robert S. Chapkin
Session 4 | PUFA, lipid rafts and immune function Robert S. Chapkin
July 6, 2011 3rd WIN Symposium CONCURRENT WORKSHOPS | Workshop of the WIN Consortium Committee on standardization of biobanking and molecular analyses of biopsies in clinical trials (open to the public) STANLEY HAMILTON, Ignacio I. Wistuba
ROUND TABLE - PANEL OF EXPERTS - FORUM OF OPEN DISCUSSION WITH ATTENDEES | Monotherapies or combined therapeutics? Clinically addressing the complexity of molecular pathways in cancer: How can we develop the most relevant combination beyond individual Pharma/Biotech pipelines: a risk sharing approach for the benefit of the patient JOHN MENDELSOHN
KEYNOTE LECTURE | Challenges and opportunities in personalized cancer therapy and cooperation between the Pharmaceutical Industry and Academia. The WIN Consortium model and operational goals JOHN MENDELSOHN
SESSION 4 | STRATEGIC ALLIANCES TO FIGHT CANCER JOHN MENDELSOHN
Using biomarkers prospectively in adaptive trials Donald Berry
SESSION 7 | STRATEGIES TO IMPROVE EFFICIENCY OF CLINICAL TRIALS Donald Berry
CONCURRENT WORKSHOPS | Workshop of the WIN Consortium Scientific Committee on the design of clinical trials, data processing and access (open to the public) Razelle Kurzrock, Donald Berry
CONCLUSION | THE URGENT NEED FOR INCREASED ACCESS OF PATIENTS FROM DIVERSE POPULATIONS TO INNOVATIVE CLINICAL TRIALS JOHN MENDELSOHN
General Assembly of the WIN Consortium (business meeting, restricted to members and open to non members by request and invitation only) JOHN MENDELSOHN
May 26, 2011 Idibell Cancer Conference on Metastasis and Angiogenesis MicroRNA-200 | A Sensor of the Extracellular Milieu and Regulator of Metastasis Jonathan M. Kurie,
May 2, 2011 LIPID MAPS Annual Meeting 2011: Lipidomics Impact on Cell Biology, Cancer, and Metabolic Diseases Characterization of new post-transcriptional regulators of fatty acid synthesis Jay Horton
April 4, 2011 RNAi & Single Cell Biology-2011 Summit TBA Alex Bishop
The role of microRNAs in Vegf signaling, and angiogenesis David Lawson
March 27, 2011 Congress on Steroid Research Metabolic impact of sex hormones on obesity Deborah Joy Clegg
March 27, 2011 Autophagy (D1) Workshop 2: Autophagy and Disease: A Clinical Point of View Beth Levine
Autophagy and Exercise Beth Levine
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) Th17 Cells Contribute to Intestinal Homeostasis by Inducing Intestinal IgA and pIgR Expression Anthony Cao
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Harnessing the Cell Biology of Dendritic Cells against Cancer (Joint) | Plasmacytoid DC in Cancer Yong-Jun Liu
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium Interpretation of biomarker studies Lajos Pusztai
MicroRNA in medical practice George A. Calin
Cancers are stressed too: exploiting cancer stress for new therapies Garth Powis
October 27, 2010 Colorectal Cancer: Biology to Therapy Inflammation and cancer: Impact of COX-2 and other inflammatory mediators Raymond N DuBois
September 27, 2010 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers Therapy of Cancer Metastasis: Attacking the Stroma Isaiah J. Fidler
The Biology of Cancer Metastasis Isaiah J. Fidler
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR Special Presentation | Title to be announced S. Ward Casscells
The biology behind the successes and failures of VEGF-targeted therapies Lee M Ellis
Comparing genomics of primary tumors and metastases for targets identification and biomarkers development in lung cancer Ignacio I. Wistuba
July 11, 2010 Translational Cancer Medicine 2010 (USA) Toward personalized therapy for advanced non-small cell lung cancer: The M. D. Anderson BATTLE Programs Roy S. Herbst
July 7, 2010 WIN Symposium in personalized cancer medicine Personalized targeted therapy in lung cancer: winning the battle and paradigm shift. Waun Ki Hong
Individualized prevention, early detection and treatment as ways to decrease cancer mortality and improve patient outcomes. JOHN MENDELSOHN
Welcome address JOHN MENDELSOHN
Next generation of biomarkers and tracers for increased diagnostic sensitivity of lung cancer. JURI GELOVANI
Integration of systems biology concepts into clinical trials. Lajos Pusztai
Breakthrough in individualized cancer treatment: innovative therapeutic developments (2) JOHN MENDELSOHN
Breakthrough in individualized cancer treatment: new scientific concepts and technological achievements (1) Ignacio I. Wistuba
Regulatory, financial and societal challenges of new technologies and methods Ignacio I. Wistuba
Open Interactive Forum JOHN MENDELSOHN
Keynote Lecture | Societal challenges of personalized medicine: STANLEY HAMILTON
May 19, 2010 Engineering Antibodies A Computational-Experimental Strategy for the Isolation of Antigen-Specific Antibodies from Immunized Animals George Georgiou
Chairperson’s Opening Remarks George Georgiou
In vitro screening or immunization? Isolating biologically active antibodies George Georgiou
May 3, 2010 LIPID MAPS Annual Meeting 2010: Lipidomics Impact on Cell Biology, Atherosclerosis and Inflammatory Disease Lipid-protein interactions as a determinant of membrane protein structure and function William Dowhan
Sterol analysis in mammalian cells and tissues David Russell
April 30, 2010 Retinal Ganglion Cells Gene regulatory networks in retinal ganglion cell development and optic nerve degeneration W. H. Klein
April 11, 2010 Synapses: Formation, Function and Misfunction (Z3) * PI3 Kinase Dysfunction | Ballroom 2 Luis F Parada
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis Systems Approach to Biomarker Identification Gordon Mills
August 11, 2009 Inaugural Molecular Diagnostics for Infectious Disease Next Generation Microbial Genomics George Weinstock
Emerging and Re-Emerging Infectious Diseases: Molecular Diagnostic Approaches Juan P. Olano
June 9, 2009 Cell and Tissue-Based Assays for HTS A Novel Platform for High-Throughput Gene Expression Profiling Andreas Jeromin
January 6, 2009 Angiogenesis and Lymphangiogenesis in Cancer (A2) Current Clinical Status of Anti-Angiogenic Therapy for Cancer Lee M Ellis, John V Heymach
October 21, 2008 20th EORTC - NCI - AACR Symposium on "Molecular Targets and Cancer Therapeutics" Workshop 1 Animal models in drug development J. L. Abbruzzese
Plenary session 10 Challenges in the development of anti bodies and antibody conjugates Chris H. Takimoto
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
cancer genetics-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
developmental therapeutics-- c-MET Inhibition for Cancer Treatment Razelle Kurzrock
developmental therapeutics-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
developmental therapeutics-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
gastrointestinal (colorectal) cancer-- Advances in Anal Cancer Management (M01) Cathy Eng
gastrointestinal (colorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
gastrointestinal (noncolorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
genitourinary cancer-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies CPO20A) Paul Mathew
genitourinary cancer What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
gynecologic cancer-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
lung cancer-- Therapeutic Modalities for “Small” Stage I Lung Cancers Robert Timmerman
lymphoma and plasma cell disorders-- The Role of Maintenance Therapy in Follicular Lymphoma: Pros and Cons Peter McLaughlin
patient and survivor care-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
patient and survivor care-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
sarcoma/bone and soft tissue cancers-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
tumor biology-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
meet the professor sessions-- Advances in Anal Cancer Management (M01) Cathy Eng
meet the professor sessions-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
meet the professor sessions-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
meet the professor sessions-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
meet the professor sessions-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20A) Paul Mathew
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
May 7, 2008 2nd annual Lab-on-a-Chip World Congress Development of a fully integrated lab-on-a-chip point of care system for the monitoring of the immune function Pierre Floriano
Next Generation Cardiac Diagnostics Using Lab-on-a-Chip Sensors and Oral Fluids Nicolaos Christodoulides
April 13, 2008 Cell Biology of Virus Entry, Replication and Pathogenesis Immune Evasion and Subversion of Host Defense Beth Levine
April 6, 2008 Islet and Beta Cell Development and Transplantation Emerging Technologies for Beta-Cell Research Thomas Kodadek
March 25, 2008 PATHWAY ANALYSIS Non Coding RNAs Involvement in Cancer Predisposition and Tumor Development George A. Calin
March 2, 2008 VIRAL VECTORS FOR GENE THERAPY, THE SCIENCE OF Ligand-Directed Vascular Targeting and Molecular Imaging Renata Pasqualini
February 24, 2008 Tumor Suppressors and Stem Cell Biology Stem Cells and Cancer Luis F Parada
February 11, 2008 Stem Cells World Congress Expansion and Engineering of Cord Blood Stem Cells L Denner
February 10, 2008 GRC - Plasminogen Activation & Extracellular Proteolysis PCSK9, a secreted protease with a non-protease function Jay Horton
February 7, 2008 Cell Death and Cellular Senescence Apoptosis Pathways in Model Organisms J M Abrams
Apoptosis Pathways in Vertebrates Guillermina Lozano
Telomeres and Senescence Guillermina Lozano
Autophagy and Host Defense Beth Levine
Autophagy, Inflammation and Apoptosis (Joint) Beth Levine
January 27, 2008 PHOTOSENSORY RECEPTORS & SIGNAL TRANSDUCTION Application of solution NMR methods to study blue-light photoreception Kevin Gardner
Discussion John Spudich
Mechanisms of Signaling by Microbial Sensory Rhodopsins John Spudich
January 20, 2008 SPIROCHETES, BIOLOGY OF Oxygen stress regulation in B. burgdorferi Janakiram Seshu
Recruitment of macrophages in Lyme carditis Rusty Montgomery
January 13, 2008 Forkhead Transcription Factor Networks in Development, Signaling, and Disease Development II Michelle C. Barton
January 13, 2008 Pathological and Physiological Regulation of Cardiac Hypertrophy MicroRNAs in Cardiac Development and Disease Eva van Rooij
Cardiac Remodeling Robert J Schwartz
Is Blocking Pathologic Hypertrophy a Good Therapeutic Strategy? Joseph A Hill
Stem Cells and Gene Therapy: The Ongoing Debate Jay W Schneider
December 1, 2007 47TH American Socieity of Cell Biology Cell Matrix Interactions (Room 140A) Muhammad H. Zaman
Cellular Biology of Gap Junction Channels (Room 103A) Guillermo Altenberg, Srikanth Polusani
Translocon-mediated Head-First Insertion and Rotation of a Signal Anchor during Cotranslational Integration. A E Johnson
Mechanism of the Neurospora Circadian Negative Feedback Loop. Yi Liu
November 29, 2007 Cell Signalling and Novel Cancer Therapeutics Key note Lecture - A systems biology approach to drug development and implementation Gordon Mills
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 2: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part I) (13:30-17:30) Dr. Xiaodong Cheng
session 2: Identification of Selective Anti-pancreatic Cancer Inhibitors Using Synthetic Lethal Chemical Screening (14:30-14:50) Dr. Xiaodong Cheng
Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Stanley J. Watowich
Session 11: Global Grid-computing Initiative to Discover Novel Dengue and Hepatitis C Antivirals (09:40-10:00) Stanley J. Watowich
November 4, 2007 2007 International Symposium On Protein Modification And Degradation Session 4: Ubiquitin and Ubiquitin-like Proteins in Signaling Zhijian James Chen
November 3, 2007 Neuroscience 2007 37th annual meeting of the Society for Neuroscience New Directions in Data Mining: Synergistic Enhancements of Online Journals and Databases Masashi Yanagisawa
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) Genome Resequencing for Mutation Screening (13:30-18:30) George A. Calin
Genome Resequencing for Mutation Screening: Toward a Non-Coding RNA Revolution in the Cancer Society (14:50-15:20) George A. Calin
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) NUCLEAR HORMONE RECEPTORS (14:10-18:50) Carole R. Mendelson
NUCLEAR HORMONE RECEPTORS: Progesterone Receptor Modulation of Inflammatory Signaling in Pregnancy and Labor (17:20-17:50) Carole R. Mendelson
August 5, 2007 Assembly of the Mitochondrial Respiratory Chain Out with a bang not a whimper: The convergence of retrograde regulation with mtDNA stability Ron Butow
July 28, 2007 Lipid Droplets: Metabolic Consequences of the Storage of Neutral Lipids Surprises from a yeast screen for lipid body assembly mutants Joel M Goodman
July 21, 2007 Microbial Pathogenesis: Mechanisms of Infectious Disease Delayed CXC ELR+ chemokine expression during early primary plague pneumonia contributes to disease severity Peter H Dube
Inter-kingdom signaling in bacterial pathogenesis Vanessa Sperandio
June 16, 2007 Thrombospondins and other Matricellular Proteins In Tissue Organization and Homeostasis Tissue Genesis and Repair Jacqueline T Hecht
Insights into COMP/TSP5 related causes of abnormal skeletogenesis Jacqueline T Hecht
June 9, 2007 Transport ATPases: Structure, Mechanisms, Genomics and Disease The mechanochemistry of ABC Transporters Philip J Thomas
V-ATPases in cancer and angiogenesis Raul Martinez Zaguilan
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.